Copyright Reports & Markets. All rights reserved.

Global Pet Pharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Pet Pharmaceuticals
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pet Pharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Antiparasitic
    • 1.3.3 Biological Products
    • 1.3.4 Antibacterial
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pet Pharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Prevention
    • 1.4.3 Treatment
  • 1.5 Global Pet Pharmaceuticals Market Size & Forecast
    • 1.5.1 Global Pet Pharmaceuticals Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Pet Pharmaceuticals Sales Quantity (2018-2029)
    • 1.5.3 Global Pet Pharmaceuticals Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Zoetis
    • 2.1.1 Zoetis Details
    • 2.1.2 Zoetis Major Business
    • 2.1.3 Zoetis Pet Pharmaceuticals Product and Services
    • 2.1.4 Zoetis Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Zoetis Recent Developments/Updates
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Pet Pharmaceuticals Product and Services
    • 2.2.4 Boehringer Ingelheim Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Pet Pharmaceuticals Product and Services
    • 2.3.4 Merck Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Elanco
    • 2.4.1 Elanco Details
    • 2.4.2 Elanco Major Business
    • 2.4.3 Elanco Pet Pharmaceuticals Product and Services
    • 2.4.4 Elanco Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Elanco Recent Developments/Updates
  • 2.5 Virbac
    • 2.5.1 Virbac Details
    • 2.5.2 Virbac Major Business
    • 2.5.3 Virbac Pet Pharmaceuticals Product and Services
    • 2.5.4 Virbac Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Virbac Recent Developments/Updates
  • 2.6 Dechra Veterinary Products
    • 2.6.1 Dechra Veterinary Products Details
    • 2.6.2 Dechra Veterinary Products Major Business
    • 2.6.3 Dechra Veterinary Products Pet Pharmaceuticals Product and Services
    • 2.6.4 Dechra Veterinary Products Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Dechra Veterinary Products Recent Developments/Updates
  • 2.7 Ceva
    • 2.7.1 Ceva Details
    • 2.7.2 Ceva Major Business
    • 2.7.3 Ceva Pet Pharmaceuticals Product and Services
    • 2.7.4 Ceva Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Ceva Recent Developments/Updates
  • 2.8 Vetoquinol
    • 2.8.1 Vetoquinol Details
    • 2.8.2 Vetoquinol Major Business
    • 2.8.3 Vetoquinol Pet Pharmaceuticals Product and Services
    • 2.8.4 Vetoquinol Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Vetoquinol Recent Developments/Updates
  • 2.9 Ouro Fino Saude
    • 2.9.1 Ouro Fino Saude Details
    • 2.9.2 Ouro Fino Saude Major Business
    • 2.9.3 Ouro Fino Saude Pet Pharmaceuticals Product and Services
    • 2.9.4 Ouro Fino Saude Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Ouro Fino Saude Recent Developments/Updates
  • 2.10 Norbrook
    • 2.10.1 Norbrook Details
    • 2.10.2 Norbrook Major Business
    • 2.10.3 Norbrook Pet Pharmaceuticals Product and Services
    • 2.10.4 Norbrook Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Norbrook Recent Developments/Updates
  • 2.11 Jindun
    • 2.11.1 Jindun Details
    • 2.11.2 Jindun Major Business
    • 2.11.3 Jindun Pet Pharmaceuticals Product and Services
    • 2.11.4 Jindun Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Jindun Recent Developments/Updates
  • 2.12 Chopperlvya Animal Health
    • 2.12.1 Chopperlvya Animal Health Details
    • 2.12.2 Chopperlvya Animal Health Major Business
    • 2.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Product and Services
    • 2.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Chopperlvya Animal Health Recent Developments/Updates
  • 2.13 CAHIC
    • 2.13.1 CAHIC Details
    • 2.13.2 CAHIC Major Business
    • 2.13.3 CAHIC Pet Pharmaceuticals Product and Services
    • 2.13.4 CAHIC Pet Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 CAHIC Recent Developments/Updates

3 Competitive Environment: Pet Pharmaceuticals by Manufacturer

  • 3.1 Global Pet Pharmaceuticals Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Pet Pharmaceuticals Revenue by Manufacturer (2018-2023)
  • 3.3 Global Pet Pharmaceuticals Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Pet Pharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Pet Pharmaceuticals Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Pet Pharmaceuticals Manufacturer Market Share in 2022
  • 3.5 Pet Pharmaceuticals Market: Overall Company Footprint Analysis
    • 3.5.1 Pet Pharmaceuticals Market: Region Footprint
    • 3.5.2 Pet Pharmaceuticals Market: Company Product Type Footprint
    • 3.5.3 Pet Pharmaceuticals Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pet Pharmaceuticals Market Size by Region
    • 4.1.1 Global Pet Pharmaceuticals Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Pet Pharmaceuticals Consumption Value by Region (2018-2029)
    • 4.1.3 Global Pet Pharmaceuticals Average Price by Region (2018-2029)
  • 4.2 North America Pet Pharmaceuticals Consumption Value (2018-2029)
  • 4.3 Europe Pet Pharmaceuticals Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Pet Pharmaceuticals Consumption Value (2018-2029)
  • 4.5 South America Pet Pharmaceuticals Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Pet Pharmaceuticals Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 5.2 Global Pet Pharmaceuticals Consumption Value by Type (2018-2029)
  • 5.3 Global Pet Pharmaceuticals Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 6.2 Global Pet Pharmaceuticals Consumption Value by Application (2018-2029)
  • 6.3 Global Pet Pharmaceuticals Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 7.2 North America Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 7.3 North America Pet Pharmaceuticals Market Size by Country
    • 7.3.1 North America Pet Pharmaceuticals Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Pet Pharmaceuticals Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 8.2 Europe Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 8.3 Europe Pet Pharmaceuticals Market Size by Country
    • 8.3.1 Europe Pet Pharmaceuticals Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Pet Pharmaceuticals Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Pet Pharmaceuticals Market Size by Region
    • 9.3.1 Asia-Pacific Pet Pharmaceuticals Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Pet Pharmaceuticals Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 10.2 South America Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 10.3 South America Pet Pharmaceuticals Market Size by Country
    • 10.3.1 South America Pet Pharmaceuticals Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Pet Pharmaceuticals Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pet Pharmaceuticals Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Pet Pharmaceuticals Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Pet Pharmaceuticals Market Size by Country
    • 11.3.1 Middle East & Africa Pet Pharmaceuticals Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Pet Pharmaceuticals Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Pet Pharmaceuticals Market Drivers
  • 12.2 Pet Pharmaceuticals Market Restraints
  • 12.3 Pet Pharmaceuticals Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pet Pharmaceuticals and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pet Pharmaceuticals
  • 13.3 Pet Pharmaceuticals Production Process
  • 13.4 Pet Pharmaceuticals Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pet Pharmaceuticals Typical Distributors
  • 14.3 Pet Pharmaceuticals Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Pet pharmaceutical refers specifically to medicines given to pets.
    In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
    In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
    According to our (Global Info Research) latest study, the global Pet Pharmaceuticals market size was valued at USD 14680 million in 2022 and is forecast to a readjusted size of USD 23120 million by 2029 with a CAGR of 6.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
    This report is a detailed and comprehensive analysis for global Pet Pharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Pet Pharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Pet Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Pet Pharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Pet Pharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pet Pharmaceuticals
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pet Pharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, Elanco and Virbac, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Pet Pharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Antiparasitic
    Biological Products
    Antibacterial
    Others
    Market segment by Application
    Prevention
    Treatment
    Major players covered
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pet Pharmaceuticals product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pet Pharmaceuticals, with price, sales, revenue and global market share of Pet Pharmaceuticals from 2018 to 2023.
    Chapter 3, the Pet Pharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pet Pharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pet Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pet Pharmaceuticals.
    Chapter 14 and 15, to describe Pet Pharmaceuticals sales channel, distributors, customers, research findings and conclusion.

    Buy now